Publisher Correction: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin

Jérémy H Raymond^{1

2}, Zackie Aktary^{1

2}, Marie Pouteaux^{1

2}, Valérie Petit^{1

2}, Flavie Luciani^{1

2}, Maria Wehbe^{1

2}, Patrick Gizzi³, Claire Bourban³, Didier Decaudin⁴, Fariba Nemati⁴, Igor Martianov⁵, Irwin Davidson⁵, Catherine-Laure Tomasetto⁵, Richard M White⁶, Florence Mahuteau-Betzer^{7

8}, Béatrice Vergier⁹, Lionel Larue^#^{10

11}, Véronique Delmas^#^{1

2}

Affiliations

¹ Normal and Pathological Development of Melanocytes, Institut Curie, PSL Research University, INSERM U1021, Orsay, France.
² Université Paris-Saclay, CNRS UMR 3347, Orsay, France.
³ CNRS UMS3286, Plateforme de Chimie Biologique Intégrative de Strasbourg, Strasbourg University/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France.
⁴ Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, Paris, France.
⁵ IGBMC, CNRS UMR7104, INSERM U1258, Université de Strasbourg, Illkirch, France.
⁶ Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK.
⁷ CNRS UMR9187, INSERM U1196, Chemistry and Modeling for the Biology of Cancer, Institut Curie, Université PSL, Orsay, France.
⁸ Université Paris-Saclay, CNRS UMR 9187, INSERM U1196, Orsay, France.
⁹ Service de pathologie CHU de Bordeaux et Eq. Translational Research on Oncodermatology and Orphean Skin Diseases (TRIO2) BoRdeaux Institute of onCology (BRIC) UMR 1312, INSERM/Université de Bordeaux, Bordeaux, France.
¹⁰ Normal and Pathological Development of Melanocytes, Institut Curie, PSL Research University, INSERM U1021, Orsay, France. lionel.larue@curie.fr.
¹¹ Université Paris-Saclay, CNRS UMR 3347, Orsay, France. lionel.larue@curie.fr.

^# Contributed equally.

Published Erratum

Jérémy H Raymond et al. Nature. 2025 Jul.

. 2025 Jul;643(8074):E28.

doi: 10.1038/s41586-025-09353-9.

¹ Normal and Pathological Development of Melanocytes, Institut Curie, PSL Research University, INSERM U1021, Orsay, France.
² Université Paris-Saclay, CNRS UMR 3347, Orsay, France.
³ CNRS UMS3286, Plateforme de Chimie Biologique Intégrative de Strasbourg, Strasbourg University/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France.
⁴ Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, Paris, France.
⁵ IGBMC, CNRS UMR7104, INSERM U1258, Université de Strasbourg, Illkirch, France.
⁶ Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK.
⁷ CNRS UMR9187, INSERM U1196, Chemistry and Modeling for the Biology of Cancer, Institut Curie, Université PSL, Orsay, France.
⁸ Université Paris-Saclay, CNRS UMR 9187, INSERM U1196, Orsay, France.
⁹ Service de pathologie CHU de Bordeaux et Eq. Translational Research on Oncodermatology and Orphean Skin Diseases (TRIO2) BoRdeaux Institute of onCology (BRIC) UMR 1312, INSERM/Université de Bordeaux, Bordeaux, France.
¹⁰ Normal and Pathological Development of Melanocytes, Institut Curie, PSL Research University, INSERM U1021, Orsay, France. lionel.larue@curie.fr.
¹¹ Université Paris-Saclay, CNRS UMR 3347, Orsay, France. lionel.larue@curie.fr.

^# Contributed equally.

No abstract available

Erratum for

Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin.
Raymond JH, Aktary Z, Pouteaux M, Petit V, Luciani F, Wehbe M, Gizzi P, Bourban C, Decaudin D, Nemati F, Martianov I, Davidson I, Tomasetto CL, White RM, Mahuteau-Betzer F, Vergier B, Larue L, Delmas V. Raymond JH, et al. Nature. 2025 Jul;643(8072):801-809. doi: 10.1038/s41586-025-09111-x. Epub 2025 Jun 11. Nature. 2025. PMID: 40500450 Free PMC article.